This image is not available for purchase in your country.

VaxSyn AIDS vaccine: injection of clinical trials

VaxSyn AIDS vaccine: injection of clinical trials

M715/0129

Rights Managed

This image is not available for purchase in your country.

Please contact your Account Manager if you have any query.

Credit

HANK MORGAN / SCIENCE PHOTO LIBRARY HANK MORGAN / SCIENCE PHOTO LIBRARY

Caption

Doctor injecting VaxSyn, an experimental form of AIDS vaccine, into an HIV-positive patient's arm during the vaccine's clinical trials. VaxSyn is an engineered, recombinant form of the HIV protein gp160, the precursor to the outer surface protein of the virus. VaxSyn contains no attenuated infectious parts of HIV & therefore carries no risk of transmitting AIDS. The vaccine is being developed by MicroGeneSys and is undergoing trials as a treatment of HIV-positive patients & as a potential vaccine against HIV infection.

Release details

Model release not available. Property release not required.

 {{ i.shot_duration ? i.shot_duration + ' ' : '' }}{{ i.shot_uhd ? '4K ' : i.hires ? 'HD ' : '' }}{{ i.spl_number }} R{{ i.license }}

  • Add to board
  • Similar {{ mediaType(i) }}